Liver Transplantation: Information on allocation of livers, recurrent HCV after transplantation, effect of race/ethnicity, immunosuppressant drugs, post transplant HCV disease progression, and pediatric issues.





S1736. Impact of Extended Criteria Donor Livers on Survival of Patients with Hepatocellular Carcinoma (updated, May 28)



o       2. Use of hepatitis C-infected donors in liver transplantation: a case-control study (updated, May 28)

o       S1729. Effect of Pre-Transplant Hepatitis C Virus RNA Status on Post-Transplant Outcome (updated, May 20)

o       S1731. Extended Donor Criteria Liver Allografts Maximize Donor Utility and Access to Transplantation (updated, May 23)

o       S1735. Distinct Differences in Global Immune Cell Function Profiles Between HCV(+) and HCV(-) Post-liver Transplant Patients (updated, May 20)

o       S1738. Diabetes Mellitus Is An Independent Predictor Of Late Mortality Following Orthotopic Liver Transplantation (updated, May 20)

o       T1028. The Effect of Liver Transplantation on Autonomic Dysfunction in Patients with End-Stage Liver Disease.


        Post Transplant

o       S1743. The use of old donors increases the risk of graft loss in the first year after liver transplantation because of non anastomotic bliliary strictures (updated, May 20)

o       S1758. Causes of Death Associated With Hepatitis B or Hepatitis C Virus Infections in a Long-Term Population-Based Cohort Study


        218. Recurrent Hepatitis C After Liver Transplantation: On-Treatment Prediction Of Response To Peginterferon Alpha-2a/Ribavirin (Peg/Rbv) Therapy



o       S1732. Blacks have worse graft and overall survival at 2 years after OLT in the MELD era (updated, May 20)